It's not just Adderall: The number of drugs in short supply rose by 30% last year
Healthcare,Drug Policy,Health,US Congress,US Senate,Supply Chains,Foreign Affairs,Big Pharma
It's not just your imagination: Drugs such as children's flu medication, common antibiotics and ADHD treatments are getting harder to buy, according to a Senate report published Wednesday.
Democrats on the Homeland Security and Governmental Affairs Committee say the number of new drug shortages rose by 30% between 2021 and 2022, an increase that has had "devastating consequences" for patients and doctors.
Towards the end of 2022, a peak of 295 individual drugs were considered in short supply β impacting treatment for everything from colds to cancer.
What's behind these shortages?
The report says the pandemic stretched supply chains thinner, right when demand for over-the-counter respiratory relief was spiking.
Related Coverage
AllSides Picks
Headline Roundup
ACA Open Enrollment Begins: Can Americans Afford Rising Health Insurance Costs?
November 1st, 2026
Announcement
Why AllSides Uses the Term βAssisted Dyingβ and Not βAssisted Suicideβ
AllSides Staff
October 31st, 2026
Bias
Media Bias Alert: Are OB-GYNs Fleeing Idaho Because of Abortion Bans?
Emily Allen
October 23rd, 2026
Red Blue Translator
Big Pharma
More News about Healthcare
News from the Left
News from the Center
News from the Right
Just The News